These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34296267)

  • 1. Cancers of Unknown Primary: A Descriptive Study in the U.S. Military Health System.
    Bytnar JA; Lin J; Moncur JT; Shriver CD; Zhu K
    Mil Med; 2023 Mar; 188(3-4):e516-e523. PubMed ID: 34296267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancers of unknown primary: Survival by histologic type, demographic features, and treatment in the U.S. Military Health System.
    Bytnar JA; Lin J; Moncur JT; Shriver CD; Zhu K
    Cancer Epidemiol; 2023 Feb; 82():102316. PubMed ID: 36571909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival among patients with glioma in the US Military Health System: A comparison with patients in the Surveillance, Epidemiology, and End Results program.
    Lin J; Bytnar JA; Theeler BJ; McGlynn KA; Shriver CD; Zhu K
    Cancer; 2020 Jul; 126(13):3053-3060. PubMed ID: 32286688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Sarcoma Survival in the US Military Health System: Comparison With the SEER Program.
    Anderson AB; Kim E; Park AB; Zhu K; Lin J; Shriver CD; Potter BK
    J Am Acad Orthop Surg; 2024 Jul; 32(13):e651-e660. PubMed ID: 38684126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival among Lung Cancer Patients in the U.S. Military Health System: A Comparison with the SEER Population.
    Lin J; Kamamia C; Brown D; Shao S; McGlynn KA; Nations JA; Carter CA; Shriver CD; Zhu K
    Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):673-679. PubMed ID: 29531129
    [No Abstract]   [Full Text] [Related]  

  • 6. Five-year survival of patients with late-stage prostate cancer: comparison of the Military Health System and the U.S. general population.
    Lin J; Nousome D; Jiang J; Chesnut GT; Shriver CD; Zhu K
    Br J Cancer; 2023 Apr; 128(6):1070-1076. PubMed ID: 36609596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Survival among Colon Cancer Patients in the U.S. Military Health System and Patients in the Surveillance, Epidemiology, and End Results (SEER) Program.
    Lin J; McGlynn KA; Shriver CD; Zhu K
    Cancer Epidemiol Biomarkers Prev; 2021 Jul; 30(7):1359-1365. PubMed ID: 34162655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival among Breast Cancer Patients: Comparison of the U.S. Military Health System with the Surveillance, Epidemiology and End Results Program.
    Lin J; Hu H; Shriver CD; Zhu K
    Clin Breast Cancer; 2022 Jun; 22(4):e506-e516. PubMed ID: 34961733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Trends in the Distribution of Lung Cancer Stage at Diagnosis in the Department of Defense Cancer Registry and the Surveillance, Epidemiology, and End Results data, 1989-2012.
    Nations JA; Brown DW; Shao S; Shriver CD; Zhu K
    Mil Med; 2020 Dec; 185(11-12):e2044-e2048. PubMed ID: 32857164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of survival among small cell lung cancer patients in the U.S. military health system and those in the surveillance, epidemiology, and end results (SEER) program.
    Lin J; Kamamia C; Brown DW; Shao S; McGlynn KA; Nations JA; Carter CA; Shriver CD; Zhu K
    Ann Epidemiol; 2021 Dec; 64():132-139. PubMed ID: 34547444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer of unknown primary: Incidence rates, risk factors and survival among adolescents and young adults.
    Pavlidis N; Rassy E; Smith-Gagen J
    Int J Cancer; 2020 Mar; 146(6):1490-1498. PubMed ID: 31144291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961-2010.
    Brewster DH; Lang J; Bhatti LA; Thomson CS; Oien KA
    Cancer Epidemiol; 2014 Jun; 38(3):227-34. PubMed ID: 24726751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and therapeutic management of cancer of an unknown primary.
    Pavlidis N; Briasoulis E; Hainsworth J; Greco FA
    Eur J Cancer; 2003 Sep; 39(14):1990-2005. PubMed ID: 12957453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care.
    Luke C; Koczwara B; Karapetis C; Pittman K; Price T; Kotasek D; Beckmann K; Brown MP; Roder D
    Aust N Z J Public Health; 2008 Aug; 32(4):383-9. PubMed ID: 18782405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival in Pediatric, Adolescent, and Young Adult Patients With Sarcoma in the Military Health System: Comparison With the SEER Population.
    Vasta LM; Zanetti RC; Anderson AB; Zhu K; Potter BK; Park AB; Lin J; Shriver CD; Warwick AB
    J Pediatr Hematol Oncol; 2021 Aug; 43(6):e832-e840. PubMed ID: 34397617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities.
    Urban D; Rao A; Bressel M; Lawrence YR; Mileshkin L
    Br J Cancer; 2013 Sep; 109(5):1318-24. PubMed ID: 23860528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs).
    Pisacane A; Cascardi E; Berrino E; Polidori A; Sarotto I; Casorzo L; Panero M; Boccaccio C; Verginelli F; Benvenuti S; Dellino M; Comoglio P; Montemurro F; Geuna E; Marchiò C; Sapino A
    Virchows Arch; 2023 Mar; 482(3):463-475. PubMed ID: 36346458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival Among Patients With Multiple Myeloma in the United States Military Health System Compared to the Surveillance, Epidemiology, and End Results (SEER) Program.
    Dew A; Lin J; Darmon S; Roswarski J; Shriver C; Zhu K; Chiu A
    Clin Lymphoma Myeloma Leuk; 2024 Nov; 24(11):789-795. PubMed ID: 39034205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence rates of bladder and kidney cancers among US military servicemen: comparison with the rates in the general US population.
    Bytnar JA; McGlynn KA; Kern SQ; Shriver CD; Zhu K
    Eur J Cancer Prev; 2024 Nov; 33(6):505-511. PubMed ID: 38568164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.